The use of Akkermansia muciniphila as potential therapeutic intervention is receiving increasing attention. Health benefits attributed to this bacterium include an improvement of metabolic disorders and exerting anti-inflammatory effects. The abundance of A. muciniphila is associated with a healthy gut in early mid- and later life. However, the effects of A. muciniphila on a decline in intestinal health during the aging process are not investigated yet. We supplemented accelerated aging Ercc1-/Δ7 mice with A. muciniphila for 10 weeks and investigated histological, transcriptional and immunological aspects of intestinal health.
|Date made available||5 Mar 2019|
van der Lugt, B. M. (Creator), van Beek, A. A. (Creator), Aalvink, S. (Creator), Meijer, B. (Creator), Sovran, B. (Creator), Vermeij, W. P. (Creator), Brandt, R. M. C. (Creator), de Vos, W. M. (Creator), Savelkoul, H. F. J. (Creator), Steegenga, W. T. (Creator), Belzer, C. (Creator) (5 Mar 2019). 16S rRNA (gene) based barcoded Illumina sequencing of the microbiota in ileal and colonic luminal content of Ercc1-/Δ7 mice after 10 weeks of Akkermansia muciniphila supplementation. Wageningen University.